1. Home
  2. IMNN vs POM Comparison

IMNN vs POM Comparison

Compare IMNN & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$0.54

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo POMDOCTOR LIMITED American Depositary Shares

POM

POMDOCTOR LIMITED American Depositary Shares

SELL

Current Price

$1.54

Market Cap

5.9M

ML Signal

SELL

Company Overview

Basic Information
Metric
IMNN
POM
Founded
1982
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.9M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
IMNN
POM
Price
$0.54
$1.54
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $15.20
N/A
AVG Volume (30 Days)
133.1K
★ 2.8M
Earning Date
11-12-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.06
52 Week High
$4.35
$5.69

Technical Indicators

Market Signals
Indicator
IMNN
POM
Relative Strength Index (RSI) 23.75 53.21
Support Level $0.50 $0.14
Resistance Level $1.28 $1.78
Average True Range (ATR) 0.10 0.21
MACD -0.01 -0.03
Stochastic Oscillator 9.96 46.08

Price Performance

Historical Comparison
IMNN
POM

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About POM POMDOCTOR LIMITED American Depositary Shares

Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.

Share on Social Networks: